Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19855966 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma
Condition: Pancreatic Adenocarcinoma
Interventions: Drug: imexon;   Drug: gemcitabine

Indicates status has not been verified in more than two years